A series inhibitors of NQO1 are designed, synthesized and evaluated. The most potent compound 3d is employed as the recognition group of probe. The first functional affinity-based small-molecule probe for NQO1 is developed. Preliminary biological results demonstrated probe III is favorable for mechanistic studies and cancer diagnostic biomarker.